DNAtix

Company Overview

Snapshot

Founded in February 2018 by Ofer Lidsky, Dr. Ichak Adizes, and Dr. Tal Sines, DNAtix operates with 1–10 employees. The company holds a patent and is currently in a Pre-Funding stage. In September 2020, DNAtix was granted a US Patent for Personal Identity Management Using Blockchain Technology.

Business overview

DNAtix is developing a smart platform for cyber genetics, focusing on anonymous and encrypted genetic services. The company's core technology facilitates the analysis, storage, and transfer of digitized DNA sequences through a direct-to-consumer platform. It serves markets within the Cyber Security and Digital Health and Medical Technologies sectors, with its proprietary open-source technology designed for developers, researchers, and institutions to further their inventions and services, utilizing blockchain for data management.

Strategic signal

In September 2020, DNAtix secured a US Patent for Personal Identity Management Using Blockchain Technology. This development signals a strategic validation of the company's innovative approach to securing sensitive genetic data, reinforcing its position in the intersection of cybersecurity and biotechnology. For investors, this patent highlights the company's commitment to intellectual property and its potential for future licensing or product development in a rapidly evolving market.

Company Intelligence Q&A

What is DNAtix's primary focus?

DNAtix focuses on developing a smart platform for cyber genetics, offering anonymous and encrypted genetic services, including the analysis, storage, and transfer of digitized DNA sequences.

When was DNAtix founded and by whom?

DNAtix was founded in February 2018 by Ofer Lidsky, Dr. Ichak Adizes, and Dr. Tal Sines.

What significant intellectual property milestone did DNAtix achieve?

In September 2020, DNAtix was granted a US Patent for Personal Identity Management Using Blockchain Technology.

Has DNAtix established any partnerships for its technology?

In August 2018, Mapmygenome partnered with Digital DNAtix, a blockchain startup. Earlier, in October 2018, DNAtix and Biologix launched a pilot in Nigeria to offer advanced genetic services.

What notable technical achievement did DNAtix demonstrate with blockchain?

In June 2018, DNAtix successfully transferred Craig Venter's Y Chromosome using IBM Blockchain, following a successful transfer of DNA sequence over the Ethereum Blockchain in April 2018.